Document is current
Any future updates will be listed below
-
Authors
Alalawi, Mai
Alrajhi, Abdullah M.
Alshahrani, Walaa A.
Alotaibi, Amal H.
Alhaj Issa, Arwa
Abumostafa, Areej
Alhaj Issa, Zahra
Alshehri, Bashayer
Alyousif, Ghadah
Alkhudair, Nora
Alsuhebany, Nada
Alzahrani, Mohammed
Alghamdi, Abrar
Alrashidi, Hessah
Alenazi, Batoul A.
Alonazi, Shaden H.
Alghamdi, Abeer A.
Vishwakarma, Ramesh
Asiri, Mohammed S.
Alenazi, Abeer A.
Alotaibi, Moureq
Aldebasi, Tariq
Al Sulaiman, Khalid
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 14 May 2025
First Online: 26 May 2025
Declarations
:
: The Institutional Review Board of King Abdullah International Medical Research Center (IRB-KAIMRC), Riyadh, Saudi Arabia approved the study on November 5, 2023. The study received the IRB registration number NRC23R-637-10. All methods were performed under relevant guidelines and regulations. Participants’ confidentiality was strictly observed throughout the study using the anonymous unique serial number for each subject and restricting data only to the investigators. Informed consent was waived because of the study’s retrospective nature by the Institutional Review Board of King Abdullah International Medical Research Center (IRB-KAIMRC), Riyadh, Saudi Arabia, and the analysis used anonymous clinical data as per the policy of the local research center.
: The authors declare no competing interests.
